← Open Payments lookup

XIANGYANG LI: Open Payments

NPI 1497719132 · MILFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,374 in 185 payments from 18 companies in 2025. Trend: 2023 $43,920 · 2024 $19,356 · 2025 $3,374

Food & beverage: $3,255Education: $119
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.32$498
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$472
Alkermes, Inc.23$421
Axsome Therapeutics, Inc.16$331
Janssen Pharmaceuticals, Inc13$284
Otsuka America Pharmaceutical, Inc.12$246
Lundbeck LLC10$230
Neurocrine BioSciences, Inc.12$195
ABBVIE INC.12$186
Teva Pharmaceuticals USA, Inc.8$171

Products named: FANAPT, REXULTI, CAPLYTA, ARISTADA, INGREZZA, VRAYLAR, Auvelity, VIVITROL.

Industry payments across MA — which companies pay providers there.